|Day Low/High||211.79 / 213.36|
|52 Wk Low/High||166.88 / 213.36|
These are both defensive deals, in which the buyers want to change their image.
Pharmacy chain CVS is buying health insurer Aetna in a cash-and-stock deal that values Aetna at about $207 a share.
Insiders are already looking beyond the upcoming merger to the patron saint of disruption Amazon.
CVS is getting ready to lock up its big deal for Aetna. Bitcoin's march toward $20,000 continues despite a fresh warning from China. And Disney remains hot for Fox.
Despite the potential threat of Amazon, analysts see the entrance by the e-commerce giant as having limited on impact on CVS due to the types of customers each is targeting.
Stocks fluctuate as Senate Republicans made progress getting their tax bill over the finish line.
Stock futures move lower in a retreat from a rally a day earlier as Senate Republicans struggle to get their tax bill over the finish line.
CVS is expected to pay more than $66 billion for the health care company
U.S. stock futures are pointing to losses for Wall Street on Friday, after the Senate delays a vote on its tax reform bill over deficit concerns.
The Dow climbed more than 300 points Thursday.
The drugstore chain's deal for the insurer, which could be valued at more than $70 billion, would affect healthcare much more than retail.
The Dow Jones Industrial Average has crossed the 24,000 threshold.
Here's what you need to know for Tuesday, Nov. 21
CVS is showing red flags as investors mull Aetna acquisition.
The pharmacy chain could arrive at a deal to acquire the health insurer for more than $66 billion by the end of the month.
Jim Cramer is bullish on McDonald's, Ultra Clean Holdings, Aetna, Baozun and more.
Jim Cramer analyzes the reasons investors should be worried, and more important, why this is the pullback that presents buying opportunities.
More than one in five who signed up for Obamacare open enrollment during its first week were new customers.
Mergers reducing an industry's size to four players from five will be OK, while deals involving Chinese buyers face long odds. The jury is still out on vertically integrated deals.
Aetna (NYSE: AET) announced the launch of Aetna Medicare Rx® Select (PDP).
Former Apple CEO John Sculley has made various bets since he left the tech giants years ago. One more recent bet is on healthcare via digitally-minded PBM RxAdvance.
The drugstore beat Wall Street estimates in Q3 earnings
A deal with Rite Aid that hasn't performed and pressures from Amazon and CVS are continuing to mount.
The pharmacy chain and health insurer are working on sealing a deal north of $70 billion as early as December, Reuters reported.
Another rally in the tech sector gives the Nasdaq the energy to close out October with another record on Tuesday.
On the heels of a WSJ report on deal discussions between CVS Health and Aetna, executives at Aetna said on an earnings call Tuesday they are not commenting on rumors.
Stocks are slightly higher as tech gains kept the Nasdaq in the green.
Stocks are mixed as a surprise selloff in Pfizer shares weigh on the Dow Jones Industrial Average but tech gains keep the Nasdaq in the green.
Stock futures move higher on Tuesday, setting up for a recovery from losses a day earlier as U.S. central bankers convene for a policy meeting.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.